Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
131 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
132 Two-be SPECT/CT versus planar bone scintigraphy: Prospective comparison of reproducibility and diagnostic performance Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
133 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2021
134 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Department of Pathology Dr. Shimaa Hassan Shabaan Hassan 2021
135 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Prof. Mostafa El-Sayed Abdalones Mohamed 2021
136 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2021
137 Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2021
138 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Department of Biostatistics and Cancer Epidemiology Basma Rezk Farouk Saleh 2021
139 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2021
140 Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients Department of Clinical Pathology Eman Hosny Mohammed Ibrahim 2021